TG Therapeutics Inc
SWB:NKB2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TG Therapeutics Inc
SWB:NKB2
|
US |
|
T
|
TG Therapeutics Inc
F:NKB2
|
US |
|
Illumina Inc
NASDAQ:ILMN
|
US |
Shareholder Yield
Current shareholder yield for
NKB2 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
NKB2 Price
TG Therapeutics Inc
| Average Annual Return | 16.35% |
| Standard Deviation of Annual Returns | 62.28% |
| Max Drawdown | -89% |
| Market Capitalization | 8.5B EUR |
| Shares Outstanding | 150 928 014 |
| Percentage of Shares Shorted |
N/A
|